These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7557822)

  • 1. Sudden infant death syndrome and diphtheria-tetanus-pertussis-poliomyelitis vaccination status.
    Jonville-Bera AP; Autret E; Laugier J
    Fundam Clin Pharmacol; 1995; 9(3):263-70. PubMed ID: 7557822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden unexpected death in infants under 3 months of age and vaccination status- -a case-control study.
    Jonville-Béra AP; Autret-Leca E; Barbeillon F; Paris-Llado J;
    Br J Clin Pharmacol; 2001 Mar; 51(3):271-6. PubMed ID: 11298074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine.
    Griffin MR; Ray WA; Livengood JR; Schaffner W
    N Engl J Med; 1988 Sep; 319(10):618-23. PubMed ID: 3261837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants.
    Heininger U; Kleemann WJ; Cherry JD;
    Pediatrics; 2004 Jul; 114(1):e9-15. PubMed ID: 15231967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome risk factors.
    Hoffman HJ; Hunter JC; Damus K; Pakter J; Peterson DR; van Belle G; Hasselmeyer EG
    Pediatrics; 1987 Apr; 79(4):598-611. PubMed ID: 3493477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden infant death and immunization: an extensive epidemiological approach to the problem in France--winter 1986.
    Bouvier-Colle MH; Flahaut A; Messiah A; Jougla E; Hatton F
    Int J Epidemiol; 1989 Mar; 18(1):121-6. PubMed ID: 2722354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination and unexplained sudden death risk in Taiwanese infants.
    Huang WT; Chen RT; Hsu YC; Glasser JW; Rhodes PH
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):17-25. PubMed ID: 27891698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome.
    Walker AM; Jick H; Perera DR; Thompson RS; Knauss TA
    Am J Public Health; 1987 Aug; 77(8):945-51. PubMed ID: 3496805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of immunisation against diphtheria, pertussis and tetanus (DPT) in relation to sudden infant death syndrome.
    Essery SD; Raza MW; Zorgani A; MacKenzie DA; James VS; Weir DM; Busuttil A; Hallam N; Blackwell C
    FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):183-92. PubMed ID: 10443507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden infant death syndrome and diphtheria/tetanus toxoid/pertussis/poliomyelitis immunisation.
    Flahault A; Messiah A; Jougla E; Bouvet E; Perin J; Hatton F
    Lancet; 1988 Mar; 1(8585):582-3. PubMed ID: 2894508
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between sudden infant death syndrome and diphtheria-tetanus-pertussis immunisation: an ecological study.
    Müller-Nordhorn J; Hettler-Chen CM; Keil T; Muckelbauer R
    BMC Pediatr; 2015 Jan; 15(1):1. PubMed ID: 25626628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphtheria, pertussis, poliomyelitis, tetanus, and Haemophilus influenzae type b vaccinations and risk of eczema and recurrent wheeze in the first year of life: the KOALA Birth Cohort Study.
    Kummeling I; Thijs C; Stelma F; Huber M; van den Brandt PA; Dagnelie PC
    Pediatrics; 2007 Feb; 119(2):e367-73. PubMed ID: 17272598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden infant death syndrome in the Tel Aviv and Petah Tikva districts.
    Sivan Y; Shen G; Schonfeld T; Nitzan M; Nutman J
    Isr J Med Sci; 1992 Jul; 28(7):430-5. PubMed ID: 1463542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination and cot deaths in perspective.
    Roberts SC
    Arch Dis Child; 1987 Jul; 62(7):754-9. PubMed ID: 3498443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.
    Sun Y; Christensen J; Hviid A; Li J; Vedsted P; Olsen J; Vestergaard M
    JAMA; 2012 Feb; 307(8):823-31. PubMed ID: 22357833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedsharing and maternal smoking in a population-based survey of new mothers.
    Lahr MB; Rosenberg KD; Lapidus JA
    Pediatrics; 2005 Oct; 116(4):e530-42. PubMed ID: 16199682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible pathomechanisms of sudden infant death syndrome: key role of chronic hypoxia, infection/inflammation states, cytokine irregularities, and metabolic trauma in genetically predisposed infants.
    Prandota J
    Am J Ther; 2004; 11(6):517-46. PubMed ID: 15543094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.